Global Oral Vaccine Market 2019 Key Players, Trends, Sales, Supply, Demand, Analysis and Forecast 2025

Global Oral Vaccine Market 2019 Key Players, Trends, Sales, Supply, Demand, Analysis and Forecast 2025

“Oral Vaccine Market” adds “Global Oral Vaccine Market Professional Survey Report 2019” reports to its database.

Oral Vaccine Market:

Executive Summary

Oral vaccine is a category of vaccines which are administered orally. As opposed to the traditional vaccination method of administering them by injection, oral vaccines are administered orally. This makes them non-invasive and safe. Patients also display improved compliance and enhance clinical practicality. Special adherence is also observed in children who find painless oral administration of vaccines better than needle administration.

The report focuses on the oral vaccine market value at global, regional and company level. The report also provides market size and future prospects of the market by analyzing historical data. For all the manufacturers mentioned in the report, information such as their manufacturing sites, production, capacity, ex-factory price, revenue and their global market share is included in the report. The market is expected to grow tremendously over the forecast years 2019-2025.

Request Free Sample Report @

Market Key Player

Merck, GSK, Sanofi, Lanzhou Institute, Serum Institute, Valneva, Shanghai United Cell, Bibcol, PaxVax, Vabiotech, Tiantan Biological, EuBiologics, Panacea Biotec Ltd, Bio-Med, Halfkin Bio-Pharmaceuticals


The global oral vaccine market is segmented in three areas. This segmentation helps in analyzing the market accurately. There are mainly 3 major segments which are further divided into smaller sub-segments.

Regional Segmentation

  • North America
  • Europe
  • China
  • Japan
  • Southeast Asia
  • India

Type Segmentation

  • Rotavirus Vaccine
  • Cholera Vaccine
  • Oral Polio Vaccine, others.

Application Segmentation

  • Public
  • Private

Regional Overview

The report systematically classifies the production, apparent consumption, export and import of oral vaccines in North America, Europe, China, Japan, Southeast Asia and India. Up until 2018, the US vaccines market dominated the industry with a market share of 35%. Factors such as increasing investment from private organizations and governments and an overall increase in health awareness around the world, especially in developing nations like India, will help in the overall growth of the market. China is also a big market for oral vaccines. Development of new vaccines will also play a crucial role in generating revenue for the industry.

Industry News

In a report published in the New England Journal of Medicine, a scientist claimed to be testing a dengue vaccine called TAK-003 which is 80% effective in preventing participants from getting dengue and 95% effective in preventing severe dengue cases. This new found vaccine will greatly improve the prospects of dengue patients. Developments of new vaccines like this will drive the entire industry further in future.


For further information on this report, visit –


Media Contact
Company Name:
Contact Person: Norah Trent
Email: Send Email
Phone: +1 646 845 9349, +44 208 133 9349
City: Pune
State: Maharashtra
Country: India